A BILL 
To amend the Employee Retirement Income Security Act 
of 1974 to require a group health plan or health insur-
ance coverage offered in connection with such a plan 
to provide an exceptions process for any medication step 
therapy protocol, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Safe Step Act’’. 
4
00:59 May 21, 2021
H2163
2 
•HR 2163 IH
SEC. 2. REQUIRED EXCEPTIONS PROCESS FOR MEDICA-
1
TION STEP THERAPY PROTOCOLS. 
2
(a) IN GENERAL.—The Employee Retirement Income 
3
Security Act of 1974 is amended by inserting after section 
4
725 of such Act (29 U.S.C. 1185d) the following new sec-
5
tion: 
6
‘‘SEC. 726. REQUIRED EXCEPTIONS PROCESS FOR MEDICA-
7
TION STEP THERAPY PROTOCOLS. 
8
‘‘(a) IN GENERAL.—In the case of a group health 
9
plan or health insurance coverage offered in connection 
10
with such a plan that provides coverage of a prescription 
11
drug pursuant to a medication step therapy protocol, the 
12
plan or coverage shall— 
13
‘‘(1) implement a clear and transparent process 
14
for a participant or beneficiary (or the prescribing 
15
health care provider on behalf of the participant or 
16
beneficiary) to request an exception to such medica-
17
tion step therapy protocol, pursuant to subsection 
18
(b); and 
19
‘‘(2) where the participant or beneficiary or 
20
prescribing health care provider’s request for an ex-
21
ception to the medication step therapy protocols sat-
22
isfies the criteria and requirements of subsection (b), 
23
cover the requested drug in accordance with the 
24
terms established by the health plan or coverage for 
25
patient cost-sharing rates or amounts at the time of 
26
00:59 May 21, 2021
H2163
3 
•HR 2163 IH
the participant’s or beneficiary’s enrollment in the 
1
health plan or health insurance coverage. 
2
‘‘(b) CIRCUMSTANCES FOR EXCEPTION APPROVAL.— 
3
The circumstances requiring an exception to a medication 
4
step therapy protocol, pursuant to a request under sub-
5
section (a), are any of the following: 
6
‘‘(1) Any treatments otherwise required under 
7
the protocol, or treatments in the same pharma-
8
cological class or having the same mechanism of ac-
9
tion, have been ineffective in the treatment of the 
10
disease or condition of the participant or beneficiary, 
11
when prescribed consistent with clinical indications, 
12
clinical guidelines, or other peer-reviewed evidence. 
13
‘‘(2) Delay of effective treatment would lead to 
14
severe or irreversible consequences, and the treat-
15
ment otherwise required under the protocol is rea-
16
sonably expected to be ineffective based upon the 
17
documented physical or mental characteristics of the 
18
participant or beneficiary and the known character-
19
istics of such treatment. 
20
‘‘(3) Any treatments otherwise required under 
21
the protocol are contraindicated for the participant 
22
or beneficiary or have caused, or are likely to cause, 
23
based on clinical, peer-reviewed evidence, an adverse 
24
00:59 May 21, 2021
H2163
4 
•HR 2163 IH
reaction or other physical harm to the participant or 
1
beneficiary. 
2
‘‘(4) Any treatment otherwise required under 
3
the protocol has prevented, will prevent, or is likely 
4
to prevent a participant or beneficiary from achiev-
5
ing or maintaining reasonable and safe functional 
6
ability in performing occupational responsibilities or 
7
activities of daily living (as defined in section 
8
441.505 of title 42, Code of Federal Regulations (or 
9
successor regulations)). 
10
‘‘(5) The participant or beneficiary is stable for 
11
his or her disease or condition on the prescription 
12
drug or drugs selected by the prescribing health care 
13
provider and has previously received approval for 
14
coverage of the relevant drug or drugs for the dis-
15
ease or condition by any group health plan or health 
16
insurance issuer. 
17
‘‘(6) Other circumstances, as determined by the 
18
Secretary. 
19
‘‘(c) REQUIREMENT OF A CLEAR PROCESS.— 
20
‘‘(1) IN
GENERAL.—The process required by 
21
subsection (a)— 
22
‘‘(A) shall provide the prescribing health 
23
care provider or beneficiary or designated third- 
24
party advocate an opportunity to present such 
25
00:59 May 21, 2021
H2163
5 
•HR 2163 IH
provider’s clinical rationale and relevant med-
1
ical information for the group health plan or 
2
health insurance issuer to evaluate such request 
3
for exception; 
4
‘‘(B) shall clearly set forth all required in-
5
formation and the specific criteria that will be 
6
used to determine whether an exception is war-
7
ranted, which may require disclosure of— 
8
‘‘(i) the medical history or other 
9
health records of the participant or bene-
10
ficiary demonstrating that the participant 
11
or beneficiary seeking an exception— 
12
‘‘(I) has tried other drugs in-
13
cluded in the drug therapy class with-
14
out success; or 
15
‘‘(II) has taken the requested 
16
drug for a clinically appropriate 
17
amount of time to establish stability, 
18
in relation to the condition being 
19
treated and prescription guidelines 
20
given by the prescribing physician; or 
21
‘‘(ii) other clinical information that 
22
may be relevant to conducting the excep-
23
tion review; 
24
00:59 May 21, 2021
H2163
6 
•HR 2163 IH
‘‘(C) may not require the submission of 
1
any information or supporting documentation 
2
beyond what is strictly necessary to determine 
3
whether any of the circumstances listed in sub-
4
section (b) exists; and 
5
‘‘(D) shall clearly outline conditions under 
6
which an exception request warrants expedited 
7
resolution from the group health plan or health 
8
insurance issuer, pursuant to subsection (d)(2). 
9
‘‘(2) AVAILABILITY
OF
PROCESS
INFORMA-
10
TION.—The group health plan or health insurance 
11
issuer shall make information regarding the process 
12
required under subsection (a) readily available on 
13
the internet website of the group health plan or 
14
health insurance issuer. Such information shall in-
15
clude— 
16
‘‘(A) the requirements for requesting an 
17
exception to a medication step therapy protocol 
18
pursuant to this section; and 
19
‘‘(B) any forms, supporting information, 
20
and contact information, as appropriate. 
21
‘‘(d) TIMING
FOR
DETERMINATION
OF
EXCEP-
22
TION.—The process required under subsection (a)(1) shall 
23
provide for the disposition of requests received under such 
24
paragraph in accordance with the following: 
25
00:59 May 21, 2021
H2163
7 
•HR 2163 IH
‘‘(1) Subject to paragraph (2), not later than 
1
72 hours after receiving an initial exception request, 
2
the plan or issuer shall respond to the requesting 
3
prescriber with either a determination of exception 
4
eligibility or a request for additional required infor-
5
mation strictly necessary to make a determination of 
6
whether the conditions specified in subsection (b) 
7
are met. The plan or issuer shall respond to the re-
8
questing provider with a determination of exception 
9
eligibility no later than 72 hours after receipt of the 
10
additional required information. 
11
‘‘(2) In the case of a request under circum-
12
stances in which the applicable medication step ther-
13
apy protocol may seriously jeopardize the life or 
14
health of the participant or beneficiary, the plan or 
15
issuer shall conduct a review of the request and re-
16
spond to the requesting prescriber with either a de-
17
termination of exception eligibility or a request for 
18
additional required information strictly necessary to 
19
make a determination of whether the conditions 
20
specified in subsection (b) are met, in accordance 
21
with the following: 
22
‘‘(A) If the plan or issuer can make a de-
23
termination of exception eligibility without addi-
24
tional information, such determination shall be 
25
00:59 May 21, 2021
H2163
8 
•HR 2163 IH
made on an expedited basis, and no later than 
1
24 hours after receipt of such request. 
2
‘‘(B) If the plan or issuer requires addi-
3
tional information before making a determina-
4
tion of exception eligibility, the plan or issuer 
5
shall respond to the requesting provider with a 
6
request for such information within 24 hours of 
7
the request for a determination, and shall re-
8
spond with a determination of exception eligi-
9
bility as quickly as the condition or disease re-
10
quires, and no later than 24 hours after receipt 
11
of the additional required information. 
12
‘‘(e) MEDICATION STEP THERAPY PROTOCOL.—In 
13
this section, the term ‘medication step therapy protocol’ 
14
means a drug therapy utilization management protocol or 
15
program under which a group health plan or health insur-
16
ance issuer offering group health insurance coverage of 
17
prescription drugs requires a participant or beneficiary to 
18
try an alternative preferred, prescription drug or drugs be-
19
fore the plan or health insurance issuer approves coverage 
20
for the non-preferred drug therapy prescribed. 
21
‘‘(f) CLARIFICATION.—This section shall apply with 
22
respect to any group health plan or health insurance cov-
23
erage offered in connection with such a plan that provides 
24
coverage of a prescription drug pursuant to a policy that 
25
00:59 May 21, 2021
H2163
9 
•HR 2163 IH
meets the definition of the term ‘medication step therapy 
1
protocol’ in subsection (e), regardless of whether such pol-
2
icy is described by such group health plan or health insur-
3
ance coverage as a step therapy protocol.’’. 
4
(b) CLERICAL AMENDMENT.—The table of contents 
5
in section 1 of the Employee Retirement Income Security 
6
Act of 1974 (29 U.S.C. 1001 et seq.) is amended by in-
7
serting after the item relating to section 725 the following 
8
new items: 
9
‘‘Sec. 726. Required exceptions process for medication step therapy protocols.’’. 
(c) EFFECTIVE DATE.— 
10
(1) IN
GENERAL.—The amendment made by 
11
subsection (a) applies with respect to plan years be-
12
ginning with the first plan year that begins at least 
13
6 months after the date of the enactment of this 
14
Act. 
15
(2) REGULATIONS.—Not later than 6 months 
16
after the date of the enactment of this Act, the Sec-
17
retary of Labor shall issue final regulations, through 
18
notice and comment rulemaking, to implement the 
19
provisions of section 726 of the Employee Retire-
20
ment Income Security Act of 1974, as added by sub-
21
section (a). 
22
Æ 
00:59 May 21, 2021
H2163
